Literature DB >> 23534983

Symptomatic exercise-induced left ventricular outflow tract obstruction without left ventricular hypertrophy.

Eyad K Alhaj1, Bette Kim, Deborah Cantales, Seth Uretsky, Farooq A Chaudhry, Mark V Sherrid.   

Abstract

BACKGROUND: Left ventricular (LV) outflow tract obstruction (LVOTO) is most commonly seen in patients with hypertrophic cardiomyopathy. Postexercise dynamic LVOTO (DLVOTO) has been infrequently identified in symptomatic patients without LV hypertrophy, and its pathophysiology is not well established. The aim of this study was to identify echocardiographic abnormalities that might explain the dynamic development of systolic anterior motion, mitral-septal contact, and LVOTO in these patients.
METHODS: Patients with DLVOTO and normal wall thickness were compared with 20 age-matched and gender-matched controls with normal stress echocardiographic findings. Two other groups were also compared: patients with DLVOTO and mild segmental hypertrophy (segmental wall thickness ≤15 mm) and patients with normal left ventricles but DLVOTO after dobutamine stress.
RESULTS: Six symptomatic patients were identified (mean age, 48 ± 9 years; range, 37-60 years; five men) with normal wall thickness who developed DLVOTO after exercise during a 6-year period. Five had been hospitalized for cardiac symptoms. The mean postexercise LV outflow tract gradient caused by systolic anterior motion mitral-septal contact was 107 ± 55 mm Hg (range, 64-200 mm Hg). All patients had echocardiographic LV wall thicknesses in the normal range (≤12 mm). Structural abnormalities of the mitral valve were identified in all six patients. These were elongated posterior leaflets (2.0 vs 1.5 cm, P < .0005), elongated anterior leaflets (3.2 vs 2.6 cm, P = .015), increased protrusion height of the mitral valve beyond the mitral annular plane (2.6 vs 0.6 cm, P < .00001), and residual protruding portions of the mitral valve leaflets (0.85 vs 0.24 cm, P < .005). There was anterior positioning of the papillary muscles in the LV cavity, with a greater distance from the plane of the papillary muscles to the posterior wall (1.8 vs 1.3 cm, P = .03). In two patients, potentially provoking medications were stopped; two patients received β-blockers, with reductions of angina. Medium-term prognosis was good; no patient had died after 3.5 years. The mitral valve abnormalities in the 10 patients with DLVOTO and mild segmental hypertrophy were qualitatively and quantitatively very similar to those in patients with DLVOTO without hypertrophy. In contrast, the valves of patients with dobutamine stress DLVOTO were not elongated, but 50% had residual mitral leaflets that protruded past the coaptation point by ≥5 mm.
CONCLUSIONS: DLVOTO after exercise can occur in the absence of LV hypertrophy and may be associated with high gradients and cardiac symptoms. Elongated, redundant mitral valve leaflets with anterior position of the papillary muscles appear to cause the postexercise obstruction.
Copyright © 2013 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534983     DOI: 10.1016/j.echo.2013.02.007

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  8 in total

1.  Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Ehud Schwammenthal; Albert A Hagège; Robert A Levine
Journal:  J Am Soc Echocardiogr       Date:  2019-03       Impact factor: 5.251

2.  Cardiogenic shock accompanied by dynamic left ventricular outflow tract obstruction and myocardial bridging after transient complete atrioventricular block mimicking ST-elevation myocardial infarction: a case report.

Authors:  Seonghui Kang; Sanghee An; Hyung Min Yu; Jiwan Kim; Sung Hea Kim; Hyun-Joong Kim; Sang Man Chung
Journal:  BMC Res Notes       Date:  2013-11-19

3.  Effect of aortic regurgitant jet direction on mitral valve leaflet remodeling: a real-time three-dimensional transesophageal echocardiography study.

Authors:  Kensuke Hirasawa; Masaki Izumo; Taro Sasaoka; Takashi Ashikaga; Kengo Suzuki; Tomoo Harada; Mitsuaki Isobe; Yoshihiro J Akashi
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  Anomalous Papillary Muscle Insertion Causing Dynamic Left Ventricular Outflow Tract Obstruction without Hypertrophic Obstructive Cardiomyopathy.

Authors:  Ravi Korabathina; Katherine Chiu; Hugh M van Gelder; Arthur Labovitz
Journal:  Case Rep Cardiol       Date:  2017-05-15

5.  Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.

Authors:  Hannah G van Velzen; Arend F L Schinkel; Myrthe E Menting; Annemien E van den Bosch; Michelle Michels
Journal:  J Ultrasound       Date:  2018-06-06

6.  Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance.

Authors:  Roy Huurman; Nikki van der Velde; Arend F L Schinkel; H Carlijne Hassing; Ricardo P J Budde; Marjon A van Slegtenhorst; Judith M A Verhagen; Alexander Hirsch; Michelle Michels
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-08-22       Impact factor: 9.130

7.  Diverse geometric changes related to dynamic left ventricular outflow tract obstruction without overt hypertrophic cardiomyopathy.

Authors:  Jung-Joon Cha; Hyemoon Chung; Young Won Yoon; Ji Hyun Yoon; Jong-Youn Kim; Pil-Ki Min; Byoung-Kwon Lee; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon; Eui-Young Choi
Journal:  Cardiovasc Ultrasound       Date:  2014-07-03       Impact factor: 2.062

Review 8.  Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice.

Authors:  Mark V Sherrid
Journal:  Curr Cardiol Rev       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.